Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 155 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1672. Clear
Clear
Q4
PUBLIC CITIZEN for PUBLIC CITIZEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products
View → Q4
TROUTMAN STRATEGIES for THE MENDED HEARTS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $60,000.00 income
Health Issues
View → Q4
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View → Q4
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $70,000.00 income
Medicare/Medicaid
View → Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View → Q4
VENABLE LLP for ASSOCIATION OF BLACK CARDIOLOGISTS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $30,000.00 income
Health Issues
View → Q3
TODD STRATEGY GROUP for NOVARTIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q3
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q3
SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → 2A
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q3
AMGEN, INC. for AMGEN INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View → Q3
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → 3T
THE MCMANUS GROUP for ALNYLAM PHARMACEUTICALS
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Medicare/Medicaid
View → Q3
BGR GOVERNMENT AFFAIRS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q3
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q3
DLA PIPER LLP (US) for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View → Q3
PUBLIC CITIZEN for PUBLIC CITIZEN
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Constitution
View → Q3
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View → Q3
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View → Q3
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $70,000.00 income
Medicare/Medicaid
View → Q3
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View → Q3
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q3
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Trade (domestic/foreign)
View → Q3
FORBES-TATE for IONIS PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid
View →
Previous Page 4 of 7 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem